for Tardive Dyskinesia in Adults

Go about
your day
with reduced
involuntary movements1

Once-daily AUSTEDO XR contains the same active ingredient as twice-daily AUSTEDO® (deutetrabenazine) tablets. Data on this page is based on twice-daily dosing.1

In a 12-week clinical study, some people taking AUSTEDO saw significant symptom improvement.1

>2x reduction

in tardive dyskinesia (TD) movements vs placebo1*

*AUSTEDO reduced the Abnormal Involuntary Movement Scale (AIMS) total score by 3.3 points vs 1.4 points with placebo. For people taking AUSTEDO, this represents a 33% reduction in AIMS total score vs a 14% reduction for those taking placebo.1


of adults experienced

MOVEMENT REDUCTION

with AUSTEDO2,3†

People taking AUSTEDO had at least a 10% reduction based
on the total motor AIMS score at Week 12.3

Some people saw a
response as early as

2 WEEKS1,2

A separate study

Established safety results for about 3 years.

This was an open-label study, which is a drug trial in which all participants are aware of the drug being tested.

Don't let TD
HOLD YOU BACK

Do you or a loved one have a TD diagnosis?

Don't let TD
HOLD YOU BACK

Are you or your loved one taking AUSTEDO XR?

Austedo XR can be taken with most mental health medications1,3

If you've taken the important step of treating your mental health, treating TD does not have to hinder your progress.

AUSTEDO XR can be taken with most mental health medications—so you can treat your TD without compromising your mental health.1,3

Learn more about how TD is diagnosed from this video.

Rebecca's partnership with her healthcare provider made it possible to diagnose her with TD and treat it with AUSTEDO

I didn't notice these things were related to a condition that was treatable. I just noticed I started having difficulty with simple tasks like cutting or buttoning, zippering, counting change.

Rebecca, living with TD

Individual results may vary.

Getting started is easy

With Teva Shared Solutions®, you have
options for
starting AUSTEDO XR. Sign up
and get support.

Enroll now

Get the conversation going

Whether you’re ready to talk to your doctor about
involuntary movements or still trying to figure out what to say, we have
an Appointment Preparation Guide to help you
start the conversation.

Start your guide

References:

1. AUSTEDO® XR (deutetrabenazine) extended-release tablets/AUSTEDO® tablets current Prescribing Information. Parsippany, NJ: Teva Neuroscience, Inc.

2. Anderson KE, Stamler D, Davis MD, et al. Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Psychiatry. 2017;4(8):595-604.

3. Data on file. Parsippany, NJ: Teva Neuroscience, Inc.

4. Fernandez HH, Stamler D, Davis MD, et al. Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia. J Neurol Neurosurg Psychiatry. 2019;90(12):1317-1323.

5. Jackson R, Brams MN, Citrome L, et al. Assessment of the impact of tardive dyskinesia in clinical practice: consensus panel recommendations. Neuropsychiatr Dis Treat. 2021;17:1589-1597.

6. Jain R, Correll CU. Tardive dyskinesia: recognition, patient assessment, and differential diagnosis. J Clin Psychiatry. 2018;79(2):nu17034ah1c.

7. Warikoo N, Schwartz TL, Citrome L. Tardive dyskinesia. In: Schwartz TL, Megna J, Topel ME, eds. Antipsychotic Drugs. Nova Science Publishers, Inc.; 2013:235-258.

8. Waln O, Jankovic J. An update on tardive dyskinesia: from phenomenology to treatment. Tremor Other Hyperkinet Mov (N Y). 2013;3:tre-03-161-4138-1.

9. Tardive dyskinesia. National Alliance on Mental Illness. Accessed January 24, 2024. https://www.nami.org/About-Mental-Illness/Treatments/Mental-Health-Medications/Tardive-Dyskinesia

10. Bergland C. Is tardive dyskinesia reversible? Verywell Health. March 8, 2022. Accessed January 24, 2024. https://www.verywellhealth.com/is-tardive-dyskinesia-reversible-5217232#